A citation-based method for searching scientific literature

Rhodé M Bijlsma, Hester Wessels, Roel H P Wouters, Anne M May, Margreet G E M Ausems, Emile E Voest, Annelien L Bredenoord. Fam Cancer 2018
Times Cited: 13







List of co-cited articles
53 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics.
Sarah S Kalia, Kathy Adelman, Sherri J Bale, Wendy K Chung, Christine Eng, James P Evans, Gail E Herman, Sophia B Hufnagel, Teri E Klein, Bruce R Korf,[...]. Genet Med 2017
936
46

Patient preferences regarding incidental genomic findings discovered during tumor profiling.
Melinda L Yushak, Gang Han, Sara Bouberhan, Lianne Epstein, Michael P DiGiovanna, Sarah S Mougalian, Tara B Sanft, Maysa M Abu-Khalaf, Gina G Chung, Stacey M Stein,[...]. Cancer 2016
34
46

ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing.
Robert C Green, Jonathan S Berg, Wayne W Grody, Sarah S Kalia, Bruce R Korf, Christa L Martin, Amy L McGuire, Robert L Nussbaum, Julianne M O'Daniel, Kelly E Ormond,[...]. Genet Med 2013
30

Diagnostic clinical genome and exome sequencing.
Leslie G Biesecker, Robert C Green. N Engl J Med 2014
354
30


Managing unsolicited findings in genomics: A qualitative interview study with cancer patients.
R M Bijlsma, R H P Wouters, H Wessels, A M May, M G E M Ausems, E E Voest, A L Bredenoord. Psychooncology 2018
11
36

Oncologists' and cancer patients' views on whole-exome sequencing and incidental findings: results from the CanSeq study.
Stacy W Gray, Elyse R Park, Julie Najita, Yolanda Martins, Lara Traeger, Elizabeth Bair, Joshua Gagne, Judy Garber, Pasi A Jänne, Neal Lindeman,[...]. Genet Med 2016
77
23

Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline Testing.
Diana Mandelker, Liying Zhang, Yelena Kemel, Zsofia K Stadler, Vijai Joseph, Ahmet Zehir, Nisha Pradhan, Angela Arnold, Michael F Walsh, Yirong Li,[...]. JAMA 2017
227
23

Interest and Attitudes of Patients With Advanced Cancer With Regard to Secondary Germline Findings From Tumor Genomic Profiling.
Jada G Hamilton, Elyse Shuk, Margaux C Genoff, Vivian M Rodríguez, Jennifer L Hay, Kenneth Offit, Mark E Robson. J Oncol Pract 2017
21
23

Physicians' attitudes about multiplex tumor genomic testing.
Stacy W Gray, Katherine Hicks-Courant, Angel Cronin, Barrett J Rollins, Jane C Weeks. J Clin Oncol 2014
152
23


Eliciting preferences on secondary findings: the Preferences Instrument for Genomic Secondary Results.
Kyle B Brothers, Kelly M East, Whitley V Kelley, M Frances Wright, Matthew J Westbrook, Carla A Rich, Kevin M Bowling, Edward J Lose, E Martina Bebin, Shirley Simmons,[...]. Genet Med 2017
29
23

Public perceptions of pharmacogenetics.
Steven C Zhang, Carleton Bruce, Michael Hayden, Michael J Rieder. Pediatrics 2014
20
23

Predispositional genome sequencing in healthy adults: design, participant characteristics, and early outcomes of the PeopleSeq Consortium.
Emilie S Zoltick, Michael D Linderman, Molly A McGinniss, Erica Ramos, Madeleine P Ball, George M Church, Debra G B Leonard, Stacey Pereira, Amy L McGuire, C Thomas Caskey,[...]. Genome Med 2019
25
23

Parent and public interest in whole-genome sequencing.
Daniel S Dodson, Aaron J Goldenberg, Matthew M Davis, Dianne C Singer, Beth A Tarini. Public Health Genomics 2015
19
23

Clinical Applications of Next-Generation Sequencing in Cancer Diagnosis.
Leila Sabour, Maryam Sabour, Saeid Ghorbian. Pathol Oncol Res 2017
29
23

Stakeholder views on secondary findings in whole-genome and whole-exome sequencing: a systematic review of quantitative and qualitative studies.
Michael P Mackley, Benjamin Fletcher, Michael Parker, Hugh Watkins, Elizabeth Ormondroyd. Genet Med 2017
74
23

To share or not to share: a randomized trial of consent for data sharing in genome research.
Amy L McGuire, Jill M Oliver, Melody J Slashinski, Jennifer L Graves, Tao Wang, P Adam Kelly, William Fisher, Ching C Lau, John Goss, Mehmet Okcu,[...]. Genet Med 2011
70
23


Acceptability of, and Information Needs Regarding, Next-Generation Sequencing in People Tested for Hereditary Cancer: A Qualitative Study.
Bettina Meiser, Ben Storey, Veronica Quinn, Belinda Rahman, Lesley Andrews. J Genet Couns 2016
13
23

Unsolicited findings of next-generation sequencing for tumor analysis within a Dutch consortium: clinical daily practice reconsidered.
Rhodé M Bijlsma, Annelien L Bredenoord, Christa G Gadellaa-Hooijdonk, Martijn Pj Lolkema, Stefan Sleijfer, Emile E Voest, Margreet Gem Ausems, Neeltje Steeghs. Eur J Hum Genet 2016
18
15

Scanning the body, sequencing the genome: Dealing with unsolicited findings.
Roel H P Wouters, Candice Cornelis, Ainsley J Newson, Eline M Bunnik, Annelien L Bredenoord. Bioethics 2017
14
15

American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer Susceptibility.
Mark E Robson, Angela R Bradbury, Banu Arun, Susan M Domchek, James M Ford, Heather L Hampel, Stephen M Lipkin, Sapna Syngal, Dana S Wollins, Noralane M Lindor. J Clin Oncol 2015
327
15

Point-counterpoint. Patient autonomy and incidental findings in clinical genomics.
Susan M Wolf, George J Annas, Sherman Elias. Science 2013
159
15


Ethical, legal, and counseling challenges surrounding the return of genetic results in oncology.
Martijn P Lolkema, Christa G Gadellaa-van Hooijdonk, Annelien L Bredenoord, Peter Kapitein, Nancy Roach, Edwin Cuppen, Nine V Knoers, Emile E Voest. J Clin Oncol 2013
66
15

Germline Variants in Targeted Tumor Sequencing Using Matched Normal DNA.
Kasmintan A Schrader, Donavan T Cheng, Vijai Joseph, Meera Prasad, Michael Walsh, Ahmet Zehir, Ai Ni, Tinu Thomas, Ryma Benayed, Asad Ashraf,[...]. JAMA Oncol 2016
187
15

Reporting incidental findings in genomic scale clinical sequencing--a clinical laboratory perspective: a report of the Association for Molecular Pathology.
Madhuri Hegde, Sherri Bale, Pinar Bayrak-Toydemir, Jane Gibson, Linda Jo Bone Jeng, Loren Joseph, Jordan Laser, Ira M Lubin, Christine E Miller, Lainie F Ross,[...]. J Mol Diagn 2015
38
15

Points to consider for laboratories reporting results from diagnostic genomic sequencing.
D F Vears, K Sénécal, A J Clarke, L Jackson, A M Laberge, L Lovrecic, A Piton, K L I Van Gassen, H G Yntema, B M Knoppers,[...]. Eur J Hum Genet 2018
38
15

A taxonomy of medical uncertainties in clinical genome sequencing.
Paul K J Han, Kendall L Umstead, Barbara A Bernhardt, Robert C Green, Steven Joffe, Barbara Koenig, Ian Krantz, Leo B Waterston, Leslie G Biesecker, Barbara B Biesecker. Genet Med 2017
61
15

Integrating next-generation sequencing into pediatric oncology practice: An assessment of physician confidence and understanding of clinical genomics.
Liza-Marie Johnson, Jessica M Valdez, Emily A Quinn, April D Sykes, Rose B McGee, Regina Nuccio, Stacy J Hines-Dowell, Justin N Baker, Chimene Kesserwan, Kim E Nichols,[...]. Cancer 2017
35
15

Testing personalized medicine: patient and physician expectations of next-generation genomic sequencing in late-stage cancer care.
Fiona A Miller, Robin Z Hayeems, Jessica P Bytautas, Philippe L Bedard, Scott Ernst, Hal Hirte, Sebastien Hotte, Amit Oza, Albiruni Razak, Stephen Welch,[...]. Eur J Hum Genet 2014
67
15

Attitudes toward molecular testing for personalized cancer therapy.
Rafeek A Yusuf, Deevakar Rogith, Shelly R A Hovick, Susan K Peterson, Allison M Burton-Chase, Bryan M Fellman, Yisheng Li, Carolyn McKinney, Elmer V Bernstam, Funda Meric-Bernstam. Cancer 2015
40
15

Attitudes of patients with cancer about personalized medicine and somatic genetic testing.
Stacy W Gray, Katherine Hicks-Courant, Christopher S Lathan, Levi Garraway, Elyse R Park, Jane C Weeks. J Oncol Pract 2012
83
15

The Genomics ADvISER: development and usability testing of a decision aid for the selection of incidental sequencing results.
Yvonne Bombard, Marc Clausen, Chloe Mighton, Lindsay Carlsson, Selina Casalino, Emily Glogowski, Kasmintan Schrader, Michael Evans, Adena Scheer, Nancy Baxter,[...]. Eur J Hum Genet 2018
25
15

Next-generation sequencing in precision oncology: Patient understanding and expectations.
J Scott Roberts, Michele C Gornick, Lan Q Le, Natalie J Bartnik, Brian J Zikmund-Fisher, Arul M Chinnaiyan. Cancer Med 2019
22
15

Attitudes of nearly 7000 health professionals, genomic researchers and publics toward the return of incidental results from sequencing research.
Anna Middleton, Katherine I Morley, Eugene Bragin, Helen V Firth, Matthew E Hurles, Caroline F Wright, Michael Parker. Eur J Hum Genet 2016
115
15

The emerging clinical relevance of genomics in cancer medicine.
Michael F Berger, Elaine R Mardis. Nat Rev Clin Oncol 2018
170
15

The clinical application of genome-wide sequencing for monogenic diseases in Canada: Position Statement of the Canadian College of Medical Geneticists.
Kym Boycott, Taila Hartley, Shelin Adam, Francois Bernier, Karen Chong, Bridget A Fernandez, Jan M Friedman, Michael T Geraghty, Stacey Hume, Bartha M Knoppers,[...]. J Med Genet 2015
128
15


Was it worth it? Patients' perspectives on the perceived value of genomic-based individualized medicine.
Colin Me Halverson, Kristin E Clift, Jennifer B McCormick. J Community Genet 2016
31
15

Survey of US public attitudes toward pharmacogenetic testing.
S B Haga, J M O'Daniel, G M Tindall, I R Lipkus, R Agans. Pharmacogenomics J 2012
105
15

"I want to know what's in Pandora's Box": comparing stakeholder perspectives on incidental findings in clinical whole genomic sequencing.
Anne Townsend, Shelin Adam, Patricia H Birch, Zoe Lohn, Francois Rousseau, Jan M Friedman. Am J Med Genet A 2012
122
15

Using Facebook Advertising to Recruit Representative Samples: Feasibility Assessment of a Cross-Sectional Survey.
Lance Garrett Shaver, Ahmed Khawer, Yanqing Yi, Kris Aubrey-Bassler, Holly Etchegary, Barbara Roebothan, Shabnam Asghari, Peizhong Peter Wang. J Med Internet Res 2019
26
15



Return of incidental findings in genomic medicine: measuring what patients value--development of an instrument to measure preferences for information from next-generation testing (IMPRINT).
Caroline Savage Bennette, Susan Brown Trinidad, Stephanie M Fullerton, Donald Patrick, Laura Amendola, Wylie Burke, Fuki M Hisama, Gail P Jarvik, Dean A Regier, David L Veenstra. Genet Med 2013
58
15

Patient experiences with gene panels based on exome sequencing in clinical diagnostics: high acceptance and low distress.
A S Sie, J B Prins, W A G van Zelst-Stams, J A Veltman, I Feenstra, N Hoogerbrugge. Clin Genet 2015
16
15

Translating genomic medicine to the clinic: challenges and opportunities.
Huan Zhang, Lars Klareskog, Andreas Matussek, Stefan M Pfister, Mikael Benson. Genome Med 2019
7
28

Views of rare disease participants in a UK whole-genome sequencing study towards secondary findings: a qualitative study.
Michael P Mackley, Edward Blair, Michael Parker, Jenny C Taylor, Hugh Watkins, Elizabeth Ormondroyd. Eur J Hum Genet 2018
17
15


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.